UMediC surges 56% on ACE Market debut

Left to right: Tan Chye Suan, UMediC independent non-executive director; Lau Chee Kheong, non-independent non-executive director; Lim Taw Seong, executive director/CEO; Datuk Ng Chai Eng, non-independent non-executive chairman, Ng Chin Liang, alternative director to Ng; Lee Yee Wooi, independent non-executive director; Dr. Pakirisamy Basakaran P Thangavelu independent non-executive director

KUALA LUMPUR: UMediC Group Bhd opened 18 sen or 56.25% higher than its initial public offering price on its debut on the ACE Market of Bursa Malaysia.

On the back of strong buying interest, the stock was the top traded counter on the market with an opening volume of 11.14 million shares.